On the public citation graph
Long‐term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi‐site trial
0 signed · 244 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.280.22.1963openalex-snapshot
Last Resort: Psychosurgery and the Limits of Medicine
inferredcites →https://doi.org/10.1002/14651858.cd002207.pub4openalex-snapshot
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
inferredcites →https://doi.org/10.1007/bf02287318openalex-snapshot
The long-term outcomes of drug use by methadone maintenance patients
inferredcites →https://doi.org/10.1016/j.drugalcdep.2005.08.010openalex-snapshot
The effect of persistence of cocaine use on 12-month outcomes for the treatment of heroin dependence
inferredcites →https://doi.org/10.1016/j.drugalcdep.2012.08.002openalex-snapshot
Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: A randomized trial
inferredcites →https://doi.org/10.1016/j.drugalcdep.2012.12.008openalex-snapshot
Integrating buprenorphine maintenance therapy into federally qualified health centers: Real-world substance abuse treatment outcomes
inferredcites →https://doi.org/10.1016/j.jsat.2014.08.006openalex-snapshot
Psychological and physiological stress negatively impacts early engagement and retention of opioid-dependent individuals on methadone maintenance
inferredcites →https://doi.org/10.1016/j.jsat.2014.12.011openalex-snapshot
Discontinuation of Buprenorphine Maintenance Therapy: Perspectives and Outcomes
inferredcites →https://doi.org/10.1016/s0140-6736(14)62338-2openalex-snapshot
Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial
inferredcites →https://doi.org/10.1016/s0376-8716(01)00120-xopenalex-snapshot
Differences among out-of-treatment drug injectors who use stimulants only, opiates only or both: implications for treatment entry
inferredcites →https://doi.org/10.1037//1040-3590.4.2.207openalex-snapshot
Reliability of retrospective self-report by narcotics addicts.
inferredcites →https://doi.org/10.1080/00401706.1989.10488618openalex-snapshot
Statistical Power Analysis for the Behavioral Sciences
inferredcites →https://doi.org/10.1080/02791072.2014.921743openalex-snapshot
Patient Perspectives on Buprenorphine/Naloxone: A Qualitative Study of Retention During the Starting Treatment with Agonist Replacement Therapies (START) Study
inferredcites →https://doi.org/10.1080/10550887.2012.694598openalex-snapshot
Maintenance Medication for Opiate Addiction: The Foundation of Recovery
inferredcites →https://doi.org/10.1093/jurban/jti031openalex-snapshot
Methamphetamine-Using HIV-Positive Men Who Have Sex with Men: Correlates of Polydrug Use
inferredcites →https://doi.org/10.1097/hrp.0000000000000052openalex-snapshot
Long-Term Course of Opioid Addiction
inferredcites →https://doi.org/10.1097/hrp.0000000000000075openalex-snapshot
Medication-Assisted Treatment of Opioid Use Disorder
inferredcites →https://doi.org/10.1111/add.12333openalex-snapshot
Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi‐site trial
inferredcites →https://doi.org/10.1111/bcp.12031openalex-snapshot
Long term outcomes of pharmacological treatments for opioid dependence: does methadone still lead the pack?
inferredcites →https://doi.org/10.1111/j.1360-0443.2009.02627.xopenalex-snapshot
Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment
inferredcites →https://doi.org/10.1177/002204261004000210openalex-snapshot
Self-Report of Longitudinal Substance Use: A Comparison of the UCLA Natural History Interview and the Addiction Severity Index
inferredcites →https://doi.org/10.1177/0269881104040239openalex-snapshot
Self-Reported Psychopathology in Polydrug Users
inferredcites →https://doi.org/10.15288/jsa.2006.67.493openalex-snapshot
Correlates of Rural Methamphetamine and Cocaine Users: Results From a Multistate Community Study
inferredcites →https://doi.org/10.31887/dcns.2007.9.2/hkleberopenalex-snapshot
Pharmacologic treatments for opioid dependence: detoxification and maintenance options
inferredcites →https://doi.org/10.31887/dcns.2007.9.4/hkleberopenalex-snapshot
Pharmacologic treatments for opioid dependence: detoxification and maintenance options
inferredcites →https://doi.org/10.3310/hta11090openalex-snapshot
Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4780710openalex-extracted
Improving Engagement in Residential Treatment for Sud: Integrated-Care Qi Project
inferred← citeshttps://doi.org/10.1001/jamahealthforum.2022.4001openalex-snapshot
Coverage and Prior Authorization Policies for Medications for Opioid Use Disorder in Medicaid Managed Care
inferred← citeshttps://doi.org/10.1001/jamainternmed.2018.1052openalex-snapshot
Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2019.20622openalex-snapshot
Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2020.3711openalex-snapshot
Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2021.37238openalex-snapshot
Accessibility to Medication for Opioid Use Disorder After Interventions to Improve Prescribing Among Nonaddiction Clinics in the US Veterans Health Care System
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2024.21740openalex-snapshot
Medication for Opioid Use Disorder After Serious Injection-Related Infections in Massachusetts
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2024.54950openalex-snapshot
Mindfulness Training vs Recovery Support for Opioid Use, Craving, and Anxiety During Buprenorphine Treatment
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2025.47933openalex-snapshot
Buprenorphine Dispensing Following Medicaid Expansion Amid Unwinding in North Carolina
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2026.8497openalex-snapshot
Social Determinants of Health and 1-Year Buprenorphine Initiation Among Justice-Involved Veterans
inferred← citeshttps://doi.org/10.1001/jamapsychiatry.2026.0246openalex-snapshot
Research Ethics in Stopping Opioid Use Disorder Medication
inferred← citeshttps://doi.org/10.1002/14651858.cd011117.pub3openalex-snapshot
Opioid agonist treatment for people who are dependent on pharmaceutical opioids
inferred← citeshttps://doi.org/10.1002/emp2.12877openalex-snapshot
An evaluation of the association between specific post‐overdose care services in emergency departments and subsequent treatment engagement
inferred← citeshttps://doi.org/10.1002/jac5.1331openalex-snapshot
Mobilizing pharmacists to address the opioid crisis: A joint opinion of the ambulatory care and adult medicine practice and research networks of the American College of Clinical Pharmacy
inferred← citeshttps://doi.org/10.1002/jcop.22233openalex-snapshot
Unmet mental health and substance use treatment needs among older homeless adults: Results from the HOPE HOME Study
inferred← citeshttps://doi.org/10.1002/jhm.12837openalex-snapshot
Implementation of a comprehensive hospitalist‐led initiative to improve care for patients with opioid use disorder
inferred← citeshttps://doi.org/10.1007/164_2019_304openalex-snapshot
Clinical Trials for Opioid Use Disorder
inferred← citeshttps://doi.org/10.1007/978-3-030-16257-3_9openalex-snapshot
The Natural History, Clinical Course, and Long-Term Recovery from Opioid Use Disorders
inferred← citeshttps://doi.org/10.1007/978-3-319-55980-3_3openalex-snapshot
Randomized Controlled Trials in Substance Abuse Treatment Research: Fundamental Aspects and New Developments in Random Assignment Strategies, Comparison/Control Conditions, and Design Characteristics
inferred← citeshttps://doi.org/10.1007/978-3-319-71812-5_7openalex-snapshot
Alcohol and Drug Use Disorders
inferred← citeshttps://doi.org/10.1007/978-981-10-4358-1_12openalex-snapshot
Treatment of Opioid Dependence
inferred← citeshttps://doi.org/10.1007/s00115-019-0783-6openalex-snapshot
Neue Slow-release-Buprenorphinformulierungen zur Optimierung der Opioidsubstitution
inferred← citeshttps://doi.org/10.1007/s10461-020-03151-2openalex-snapshot
HIV Infection and Depression Among Opiate Users in a US Epicenter of the Opioid Epidemic
inferred← citeshttps://doi.org/10.1007/s10742-025-00349-6openalex-snapshot
Economic considerations of office-based methadone as an opioid use disorder treatment option: a cost-effectiveness analysis and methodological comparison
inferred← citeshttps://doi.org/10.1007/s11298-020-8112-8openalex-snapshot
Neue Therapieoptionen in der Substitutionsbehandlung
inferred← citeshttps://doi.org/10.1007/s11414-020-09706-4openalex-snapshot
Organizational Facilitators and Barriers to Medication for Opioid Use Disorder Capacity Expansion and Use
inferred← citeshttps://doi.org/10.1007/s11481-018-9801-xopenalex-snapshot
Correlates of Long-Term Opioid Abstinence After Randomization to Methadone Versus Buprenorphine/Naloxone in a Multi-Site Trial
inferred← citeshttps://doi.org/10.1007/s11757-025-00895-2openalex-snapshot
Efficacy of opioid maintenance in prison settings—how strong is the evidence? A narrative review
inferred← citeshttps://doi.org/10.1007/s11904-018-0398-8openalex-snapshot
Federal Response to the Opioid Crisis
inferred← citeshttps://doi.org/10.1007/s11916-022-01046-6openalex-snapshot
Patients on Buprenorphine Formulations Undergoing Surgery
inferred← citeshttps://doi.org/10.1007/s11920-020-01149-0openalex-snapshot
Identification and Management of Opioid Use Disorder in Primary Care: an Update
inferred← citeshttps://doi.org/10.1007/s11930-020-00282-4openalex-snapshot
Sexual Dysfunction in Persons Receiving Opioid Substitution Therapy
inferred← citeshttps://doi.org/10.1007/s13181-021-00858-zopenalex-snapshot
Methadone vs. Buprenorphine for In-Hospital Initiation: Which Is Better for Outpatient Care Retention in Patients with Opioid Use Disorder?
inferred← citeshttps://doi.org/10.1007/s15005-021-1823-xopenalex-snapshot
Synthetische Opioide: hohes psychisches und physisches Risiko
inferred← citeshttps://doi.org/10.1007/s15202-020-2847-7openalex-snapshot
Neue Therapieoptionen in der Substitutionsbehandlung
inferred← citeshttps://doi.org/10.1007/s40263-019-00637-zopenalex-snapshot
Buprenorphine Treatment for Opioid Use Disorder: An Overview
inferred← citeshttps://doi.org/10.1007/s40429-018-0203-1openalex-snapshot
Mechanisms of Behavior Change in 12-Step Approaches to Recovery in Young Adults
inferred← citeshttps://doi.org/10.1007/s40615-024-02273-wopenalex-snapshot
Racial and Ethnic Differences in Long-Term Outcomes among Individuals with Opioid Use Disorder at Opioid Treatment Programs
inferred← citeshttps://doi.org/10.1016/j.addbeh.2022.107589openalex-snapshot
Effects of buprenorphine on opioid craving in comparison to other medications for opioid use disorder: A systematic review of randomized controlled trials
inferred← citeshttps://doi.org/10.1016/j.biopsych.2019.06.020openalex-snapshot
Medication Treatment of Opioid Use Disorder
inferred← citeshttps://doi.org/10.1016/j.cct.2020.106014openalex-snapshot
Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations
inferred← citeshttps://doi.org/10.1016/j.cct.2021.106394openalex-snapshot
Design and methods of a multi-site randomized controlled trial of an integrated care model of long-acting injectable buprenorphine with infectious disease treatment among persons hospitalized with infections and opioid use disorder
inferred← citeshttps://doi.org/10.1016/j.cct.2024.107543openalex-snapshot
Discontinuation of medication treatment for opioid use disorder after a successful course: The discontinuation phase of the CTN-0100 (RDD) trial
inferred← citeshttps://doi.org/10.1016/j.cct.2026.108437openalex-snapshot
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the treatment of opioid use disorder (TAB) trial: study design and rationale
inferred← citeshttps://doi.org/10.1016/j.clnesp.2025.01.025openalex-snapshot
Pomegranate juice ameliorates craving and oxidative stress on patients under medication for opioid addiction treatment with methadone and buprenorphine: A ranzomised controlled trial
inferred← citeshttps://doi.org/10.1016/j.dadr.2022.100048openalex-snapshot
Association of chronic non-cancer pain status and buprenorphine treatment retention among individuals with opioid use disorder: Results from electronic health record data
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2019.05.003openalex-snapshot
Opioid agonist treatment reduces losses in quality of life and quality-adjusted life expectancy in heroin users: Evidence from real world data
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2019.06.018openalex-snapshot
Correlation between interleukin-6 levels and methadone maintenance therapy outcomes
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2019.107606openalex-snapshot
Association between buprenorphine/naloxone and high-dose opioid analgesic prescribing in Kentucky, 2012–2017
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2019.107799openalex-snapshot
Impact of a jail-based treatment decision-making intervention on post-release initiation of medications for opioid use disorder
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2021.108619openalex-snapshot
Perceived social support in patients with chronic pain with and without opioid use disorder and role of medication for opioid use disorder
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2021.108717openalex-snapshot
Opioid use disorder treatment for people experiencing homelessness: A scoping review
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2021.108844openalex-snapshot
The relationship between crystal methamphetamine use and methadone retention in a prospective cohort of people who use drugs
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2021.108886openalex-snapshot
An examination between treatment type and treatment retention in persons with opioid and co-occurring alcohol use disorders
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2021.108996openalex-snapshot
Psychiatric comorbidity and treatment outcomes in patients with opioid use disorder: Results from a multisite trial of buprenorphine-naloxone and methadone
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2021.109031openalex-snapshot
Optimizing opioid use disorder treatment with naltrexone or buprenorphine
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2022.109445openalex-snapshot
Systematic review and meta-analysis of changes in quality of life following initiation of buprenorphine for opioid use disorder
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2022.109497openalex-snapshot
Bridge clinic implementation of “72-hour rule” methadone for opioid withdrawal management: Impact on opioid treatment program linkage and retention in care
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2022.109609openalex-snapshot
Buprenorphine & methadone dosing strategies to reduce risk of relapse in the treatment of opioid use disorder
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2022.109669openalex-snapshot
Buprenorphine treatment episode duration, dosage, and concurrent prescribing of benzodiazepines and opioid analgesics: The effects of Medicaid prior authorization policies
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2023.109893openalex-snapshot
Cost-effectiveness of flexible take-home buprenorphine-naloxone versus methadone for treatment of prescription-type opioid use disorder
inferred← citeshttps://doi.org/10.1016/j.drugpo.2016.12.003openalex-snapshot
Causes of death and expected years of life lost among treated opioid-dependent individuals in the United States and Taiwan
inferred← citeshttps://doi.org/10.1016/j.drugpo.2020.102722openalex-snapshot
Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?
inferred← citeshttps://doi.org/10.1016/j.drugpo.2021.103480openalex-snapshot
Comparing characteristics and outcomes of different opioid agonist treatment modalities among opioid-dependent federal men correctional populations in Canada
inferred← citeshttps://doi.org/10.1016/j.japh.2020.01.001openalex-snapshot
Indiana community pharmacist preceptors’ knowledge and perceptions of medication-assisted treatment
inferred← citeshttps://doi.org/10.1016/j.jns.2020.116712openalex-snapshot
Long-term treatment retention in West Virginia's comprehensive opioid addiction treatment (COAT) program
inferred← citeshttps://doi.org/10.1016/j.jns.2020.116728openalex-snapshot
Medication-assisted therapies for opioid use disorders in patients with chronic pain
inferred← citeshttps://doi.org/10.1016/j.jns.2021.120094openalex-snapshot
Looking beyond the opioid receptor: A desperate need for new treatments for opioid use disorder
inferred← citeshttps://doi.org/10.1016/j.josat.2023.209051openalex-snapshot
Barriers and facilitators to the use of medication for opioid use disorder within the criminal justice system: Perspectives from clinicians
inferred← citeshttps://doi.org/10.1016/j.josat.2023.209053openalex-snapshot
Buprenorphine and opioid analgesics: Dispensation and discontinuity among accidental overdose fatalities in the Indianapolis metropolitan area, 2016–2021
inferred← citeshttps://doi.org/10.1016/j.josat.2023.209237openalex-snapshot
Cost-effectiveness of full and partial opioid agonists for opioid use disorder in outpatient settings: United States healthcare sector perspective
inferred← citeshttps://doi.org/10.1016/j.josat.2023.209262openalex-snapshot
Willingness to utilize a mobile treatment unit in five counties at the epicenter of the US rural opioid epidemic
inferred← citeshttps://doi.org/10.1016/j.josat.2025.209854openalex-snapshot
A clinical trial loses access to some of its experimental treatment conditions: What can be done?
inferred← citeshttps://doi.org/10.1016/j.josat.2026.210105openalex-snapshot
Cost-effectiveness of technology-assisted buprenorphine for opioid use disorder: Analysis of three randomized trials
inferred← citeshttps://doi.org/10.1016/j.josat.2026.210132openalex-snapshot
Examining patient and provider experiences in collaborative, low threshold care for substance use disorder: A qualitative study of a bridge clinic
inferred← citeshttps://doi.org/10.1016/j.jsat.2016.12.010openalex-snapshot
Long-term retention in Office Based Opioid Treatment with buprenorphine
inferred← citeshttps://doi.org/10.1016/j.jsat.2017.04.016openalex-snapshot
Relapse to opioid use disorder after inpatient treatment: Protective effect of injection naltrexone
inferred← citeshttps://doi.org/10.1016/j.jsat.2017.05.007openalex-snapshot
Addiction consultation services – Linking hospitalized patients to outpatient addiction treatment
inferred← citeshttps://doi.org/10.1016/j.jsat.2018.01.007openalex-snapshot
Concurrent drug injection during opioid agonist treatment among people who inject drugs in Ukraine
inferred← citeshttps://doi.org/10.1016/j.jsat.2018.07.008openalex-snapshot
Comparison between buprenorphine provider availability and opioid deaths among US counties
inferred← citeshttps://doi.org/10.1016/j.jsat.2019.06.015openalex-snapshot
Implementation and evaluation of Missouri's Medication First treatment approach for opioid use disorder in publicly-funded substance use treatment programs
inferred← citeshttps://doi.org/10.1016/j.jsat.2019.08.002openalex-snapshot
Effects of access barriers and medication acceptability on buprenorphine-naloxone treatment utilization over 2 years: Results from a multisite randomized trial of adults with opioid use disorder
inferred← citeshttps://doi.org/10.1016/j.jsat.2021.108447openalex-snapshot
Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse
inferred← citeshttps://doi.org/10.1016/j.jss.2025.07.019openalex-snapshot
Opioid Use Within a Year Following Discharge in Trauma Patients With Prior Opioid Use Disorder
inferred← citeshttps://doi.org/10.1016/j.mayocp.2019.03.029openalex-snapshot
Medication-Assisted Treatment for Opioid-Use Disorder
inferred← citeshttps://doi.org/10.1016/j.neubiorev.2020.04.024openalex-snapshot
Dopamine D3 receptor-based medication development for the treatment of opioid use disorder: Rationale, progress, and challenges
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2024.110048openalex-snapshot
Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy
inferred← citeshttps://doi.org/10.1016/j.nurpra.2024.105174openalex-snapshot
Improving Engagement in Residential Treatment for Substance Use Disorders: An Integrated Care Quality Improvement Project for Individuals With Mental Health and Substance Use Disorders
inferred← citeshttps://doi.org/10.1016/j.oret.2026.01.004openalex-snapshot
Substance Use Disorder Interventions and Ophthalmic Outcomes for Injection Drug Use–Associated Endogenous Endophthalmitis
inferred← citeshttps://doi.org/10.1016/j.peptides.2019.170223openalex-snapshot
Endogenous opiates and behavior: 2017
inferred← citeshttps://doi.org/10.1016/j.pnpbp.2018.01.024openalex-snapshot
Presumed structural and functional neural recovery after long-term abstinence from cocaine in male military veterans
inferred← citeshttps://doi.org/10.1016/j.psc.2018.01.011openalex-snapshot
Engineering Neurobiological Systems: Addiction
inferred← citeshttps://doi.org/10.1016/s0140-6736(17)32812-xopenalex-snapshot
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial
inferred← citeshttps://doi.org/10.1016/s2215-0366(23)00095-0openalex-snapshot
Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies
inferred← citeshttps://doi.org/10.1017/9781911623465.017openalex-snapshot
Drugs to Treat Substance Use Disorders
inferred← citeshttps://doi.org/10.1037/adb0000525openalex-snapshot
Changes in the elimination and resurgence of alcohol-maintained behavior in rats and the effects of naltrexone.
inferred← citeshttps://doi.org/10.1038/s41386-018-0232-4openalex-snapshot
Can neuroimaging help combat the opioid epidemic? A systematic review of clinical and pharmacological challenge fMRI studies with recommendations for future research
inferred← citeshttps://doi.org/10.1038/s41598-023-35673-9openalex-snapshot
Sex differences in VTA GABA transmission and plasticity during opioid withdrawal
inferred← citeshttps://doi.org/10.1055/a-1064-6188openalex-snapshot
Langwirksame Buprenorphinpräparate als neue pharmakologische Option bei Opiatabhängigkeit
inferred← citeshttps://doi.org/10.1055/a-1298-4508openalex-snapshot
Novel Long-Acting Buprenorphine Medications for Opioid Dependence: Current Update
inferred← citeshttps://doi.org/10.1056/evidra2200038openalex-snapshot
Opioid Use Disorder Diagnosis and Management
inferred← citeshttps://doi.org/10.1080/00952990.2018.1461877openalex-snapshot
Treatment outcomes among a cohort of African American buprenorphine patients: Follow-up at 12 months
inferred← citeshttps://doi.org/10.1080/00952990.2020.1797064openalex-snapshot
Variants of opioid genes and response to treatment of opioid use disorder with buprenorphine-naloxone versus extended-release naltrexone in Caucasians
inferred← citeshttps://doi.org/10.1080/00952990.2020.1849247openalex-snapshot
Add-on repetitive transcranial magnetic stimulation in patients with opioid use disorder undergoing methadone maintenance therapy
inferred← citeshttps://doi.org/10.1080/00952990.2024.2417820openalex-snapshot
Examining how support persons’ buprenorphine attitudes and their communication about substance use impacts patient well-being
inferred← citeshttps://doi.org/10.1080/03007995.2020.1846022openalex-snapshot
Safety and efficacy of a prescription digital therapeutic as an adjunct to buprenorphine for treatment of opioid use disorder
inferred← citeshttps://doi.org/10.1080/08897077.2021.2010161openalex-snapshot
Policies regarding Use of Medications for Opioid Use Disorder in Professional Recovery Programs: A Scoping Review
inferred← citeshttps://doi.org/10.1080/10439463.2026.2674973openalex-snapshot
The Portuguese police experience with drug decriminalisation
inferred← citeshttps://doi.org/10.1080/10826084.2022.2112230openalex-snapshot
Patient Characteristics Associated with Opioid Abstinence after Participation in a Trial of Buprenorphine versus Injectable Naltrexone
inferred← citeshttps://doi.org/10.1080/10826084.2026.2670603openalex-snapshot
The Implementation of Medications for Opioid Use Disorder in Recovery Residences: Assessing the Impact of the Consolidated Framework for Implementation Science Constructs
inferred← citeshttps://doi.org/10.1080/14656566.2019.1652270openalex-snapshot
Pain management in opioid maintenance treatment
inferred← citeshttps://doi.org/10.1080/14659891.2026.2711692openalex-snapshot
Contemporary patterns of methamphetamine use and misuse: neurotoxicity, dependency, and societal burden
inferred← citeshttps://doi.org/10.1080/14767058.2021.1873266openalex-snapshot
Cost effectiveness of buprenorphine vs. methadone for pregnant people with opioid use disorder
inferred← citeshttps://doi.org/10.1080/15504263.2017.1363449openalex-snapshot
Psychological Distress is Correlated with Erectile Dysfunction Among Patients Receiving Methadone Maintenance in Taiwan
inferred← citeshttps://doi.org/10.1080/15563650.2021.1893742openalex-snapshot
Methadone and suboxone ® mentions on twitter: thematic and sentiment analysis
inferred← citeshttps://doi.org/10.1080/16066359.2024.2420087openalex-snapshot
Dynamics of prescribing and accessing medications for opioid use disorder: a community-based systems analysis
inferred← citeshttps://doi.org/10.1080/17425247.2019.1649252openalex-snapshot
What place for prolonged-release buprenorphine depot-formulation Buvidal® in the treatment arsenal of opioid dependence? Insights from the French experience on buprenorphine
inferred← citeshttps://doi.org/10.1093/aje/kwac217openalex-snapshot
Optimally Choosing Medication Type for Patients With Opioid Use Disorder
inferred← citeshttps://doi.org/10.1093/ijnp/pyac069openalex-snapshot
Association Between Inflammatory Cytokines, Executive Function, and Substance Use in Patients With Opioid Use Disorder and Amphetamine-Type Stimulants Use Disorder
inferred← citeshttps://doi.org/10.1093/jamia/ocaf157openalex-snapshot
Predicting treatment retention in medication for opioid use disorder: a machine learning approach using NLP and LLM-derived clinical features
inferred← citeshttps://doi.org/10.1093/oncolo/oyae176openalex-snapshot
Efficacy of transdermal buprenorphine patch for managing withdrawal symptoms in patients with cancer physically dependent on prescription opioids
inferred← citeshttps://doi.org/10.1093/oxfordhb/9780197618431.013.23openalex-snapshot
Long-Term Treatment of Opioid Use Disorder with Medications
inferred← citeshttps://doi.org/10.1093/pm/pnaa020openalex-snapshot
Perioperative Continuation of Buprenorphine at Low–Moderate Doses Was Associated with Lower Postoperative Pain Scores and Decreased Outpatient Opioid Dispensing Compared with Buprenorphine Discontinuation
inferred← citeshttps://doi.org/10.1097/01.tpm.0000653612.18552.1eopenalex-snapshot
Long-Term Efficacy of Medication-Assisted Treatment of Opioid Addiction: A Systematic Literature Review—Part 2
inferred← citeshttps://doi.org/10.1097/adm.0000000000000274openalex-snapshot
Distinctive Trajectories of Opioid Use Over an Extended Follow-up of Patients in a Multisite Trial on Buprenorphine + Naloxone and Methadone
inferred← citeshttps://doi.org/10.1097/adm.0000000000000592openalex-snapshot
Treatment Trajectories During and After a Medication Trial for Opioid Use Disorder: Moving from Research as Usual to Treatment as Usual
inferred← citeshttps://doi.org/10.1097/adm.0000000000000608openalex-snapshot
Acceptability and Feasibility of a Mobile Health Application for Video Directly Observed Therapy of Buprenorphine for Opioid Use Disorders in an Office-based Setting
inferred← citeshttps://doi.org/10.1097/adm.0000000000001156openalex-snapshot
Clinician Perspectives on Delivering Medication Treatment for Opioid Use Disorder during the COVID-19 Pandemic: A Qualitative Evaluation
inferred← citeshttps://doi.org/10.1097/adm.0000000000001275openalex-snapshot
Buprenorphine Receipt and Retention for Opioid Use Disorder Following an Initiative to Increase Access in Primary Care
inferred← citeshttps://doi.org/10.1097/adm.0000000000001313openalex-snapshot
Machine Learning–Driven Analysis of Individualized Treatment Effects Comparing Buprenorphine and Naltrexone in Opioid Use Disorder Relapse Prevention
inferred← citeshttps://doi.org/10.1097/adm.0000000000001682openalex-snapshot
A Digital Therapeutic Mobile App, ReSET-O, as Adjunct to Medication Treatment for Opioid Use Disorder: A Randomized Clinical Trial at an Opioid Treatment Program
inferred← citeshttps://doi.org/10.1097/coh.0000000000000407openalex-snapshot
Tobacco, illicit drugs use and risk of cardiovascular disease in patients living with HIV
inferred← citeshttps://doi.org/10.1097/fbp.0000000000000880openalex-snapshot
Acute glucagon-like peptide-1 receptor agonist, semaglutide, attenuates cue-, drug-, and stress-induced fentanyl seeking in male Sprague–Dawley rats
inferred← citeshttps://doi.org/10.1101/2023.07.21.550008openalex-snapshot
Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy
inferred← citeshttps://doi.org/10.1101/2025.11.10.687622openalex-snapshot
A Challenge To The Assumption That Short- versus Long-Access Groups of Opioid Users Represent Distinct Phenotypes
inferred← citeshttps://doi.org/10.1111/adb.70159openalex-snapshot
Long‐Acting Naltrexone Restores Network Connectivity in Subjects With Comorbid Cannabis and Opioid Use Disorder
inferred← citeshttps://doi.org/10.1111/add.14188openalex-snapshot
The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom
inferred← citeshttps://doi.org/10.1111/add.14620openalex-snapshot
Criminal justice outcomes over 5 years after randomization to buprenorphine‐naloxone or methadone treatment for opioid use disorder
inferred← citeshttps://doi.org/10.1111/add.15377openalex-snapshot
Explaining differential effects of medication for opioid use disorder using a novel approach incorporating mediating variables
inferred← citeshttps://doi.org/10.1111/add.15654openalex-snapshot
Association between dynamic dose increases of buprenorphine for treatment of opioid use disorder and risk of relapse
inferred← citeshttps://doi.org/10.1111/add.16587openalex-snapshot
Predictability of buprenorphine‐naloxone treatment retention: A multi‐site analysis combining electronic health records and machine learning
inferred← citeshttps://doi.org/10.1111/add.16659openalex-snapshot
Medications for opioid use disorder: Predictors of early discontinuation and reduction of overdose risk in US military veterans by medication type
inferred← citeshttps://doi.org/10.1111/ajad.12711openalex-snapshot
Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies
inferred← citeshttps://doi.org/10.1111/ajad.12809openalex-snapshot
Methadone to buprenorphine/naloxone induction without withdrawal utilizing transdermal fentanyl bridge in an inpatient setting—Azar method
inferred← citeshttps://doi.org/10.1111/ajad.13051openalex-snapshot
A Literature Review Examining Primary Outcomes of Medication Treatment Studies for Opioid Use Disorder: What Outcome Should Be Used to Measure Opioid Treatment Success?
inferred← citeshttps://doi.org/10.1111/ajad.13060openalex-snapshot
Ten Years of Experience With Buprenorphine in a Private Psychiatric Outpatient Practice
inferred← citeshttps://doi.org/10.1111/ajad.13134openalex-snapshot
The Efficacy of Combined Electroacupuncture and Auricular Pressure on Sleep Quality in Patients Receiving Methadone Maintenance Treatment
inferred← citeshttps://doi.org/10.1111/jrh.12260openalex-snapshot
Medication‐Assisted Opioid Treatment Prescribers in Federally Qualified Health Centers: Capacity Lags in Rural Areas
inferred← citeshttps://doi.org/10.1111/jrh.70219openalex-snapshot
Methadone Versus Buprenorphine/Naloxone: Treatment Outcome Differences Among Individuals Receiving Medications for Opioid Use Disorders in Rural Treatment Settings—A 1‐Year Retrospective Cohort Study
inferred← citeshttps://doi.org/10.1111/ppc.13030openalex-snapshot
An overview of buprenorphine prescribing for the advanced practice psychiatric nurse
inferred← citeshttps://doi.org/10.1136/bcr-2017-220815openalex-snapshot
Traditional Chinese medicine-facilitated treatments may relieve anxiety symptoms during drug switching from methadone to buprenorphine/naloxone for treating opioid dependence
inferred← citeshttps://doi.org/10.1136/bmjopen-2026-118322openalex-snapshot
Methadone administration and QT interval prolongation: protocol for a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1136/injuryprev-2017-042676openalex-snapshot
Impacts of an opioid overdose prevention intervention delivered subsequent to acute care
inferred← citeshttps://doi.org/10.1155/2020/3748056openalex-snapshot
Efficacy of Electroacupuncture Combined with Auricular Point Pressing in Improving Mental Well‐Being among Individuals with Heroin Use Disorder: A Randomized Controlled Crossover Trial and Pilot Study
inferred← citeshttps://doi.org/10.1159/000468518openalex-snapshot
Six-Year Outcome of Opioid Maintenance Treatment in Heroin-Dependent Patients: Results from a Naturalistic Study in a Nationally Representative Sample
inferred← citeshttps://doi.org/10.1159/000485029openalex-snapshot
Methadone Dose Adjustments, Plasma R-Methadone Levels and Therapeutic Outcome of Heroin Users: A Randomized Clinical Trial
inferred← citeshttps://doi.org/10.1176/appi.ajp.2016.16070792openalex-snapshot
The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review
inferred← citeshttps://doi.org/10.1176/appi.ajp.21121254openalex-snapshot
Technology and Mental Health: State of the Art for Assessment and Treatment
inferred← citeshttps://doi.org/10.1176/appi.focus.17206openalex-snapshot
The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review
inferred← citeshttps://doi.org/10.1176/appi.ps.20220549openalex-snapshot
Impact of Medication-Based Treatment on Health Care Utilization Among Individuals With Opioid Use Disorder
inferred← citeshttps://doi.org/10.1176/appi.ps.20230159openalex-snapshot
An Approach to Enhancing Medication Treatment for Opioid Use Disorder in the HEALing Communities Study
inferred← citeshttps://doi.org/10.1177/00333549231222479openalex-snapshot
The Medications for Opioid Use Disorder Study: Methods and Initial Outcomes From an 18-Month Study of Patients in Treatment for Opioid Use Disorder
inferred← citeshttps://doi.org/10.1177/0269881117691453openalex-snapshot
The association of psychedelic use and opioid use disorders among illicit users in the United States
inferred← citeshttps://doi.org/10.1177/08897077231186213openalex-snapshot
Outcomes of State Targeted/Opioid Response Grants and the Medication First Approach: Evidence of Racial Inequities in Improved Treatment Access and Retention
inferred← citeshttps://doi.org/10.1177/08897077231203849openalex-snapshot
Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy
inferred← citeshttps://doi.org/10.1177/09637214231162366openalex-snapshot
Everybody Hurts: Intersecting and Colliding Epidemics and the Need for Integrated Behavioral Treatment of Chronic Pain and Substance Use
inferred← citeshttps://doi.org/10.1177/10600280211028262openalex-snapshot
Pronounced Regional Disparities in United States Methadone Distribution
inferred← citeshttps://doi.org/10.1177/1073110520979382openalex-snapshot
Perceived Benefits and Harms of Involuntary Civil Commitment for Opioid Use Disorder
inferred← citeshttps://doi.org/10.1177/1178221818784294openalex-snapshot
Empirical Studies Addressing the Opioid Epidemic: An Urgent Call for Research
inferred← citeshttps://doi.org/10.1177/1357633x251319851openalex-snapshot
Using inpatient addiction consult service via telehealth to improve pharmacotherapy initiation: An observational study
inferred← citeshttps://doi.org/10.1177/29767342241266038openalex-snapshot
Association Between Length of Buprenorphine or Methadone Use and Nonprescribed Opioid Use Among Individuals with Opioid Use Disorder: A Cohort Study
inferred← citeshttps://doi.org/10.1177/29767342251313595openalex-snapshot
Substance Use Disorder and Harm Reduction Curriculum in United States and Canadian Undergraduate Medical Education: An Online Survey
inferred← citeshttps://doi.org/10.1186/s12888-025-07132-4openalex-snapshot
“All I want is the best for my brother”: interest in a Community Reinforcement and Family Training (CRAFT)-based group intervention among concerned significant others of individuals on office-based medications for opioid use disorder
inferred← citeshttps://doi.org/10.1186/s12954-025-01157-4openalex-snapshot
Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study
inferred← citeshttps://doi.org/10.1186/s13011-021-00429-zopenalex-snapshot
Client satisfaction to methadone maintenance treatment program in Myanmar
inferred← citeshttps://doi.org/10.1186/s13722-019-0175-zopenalex-snapshot
Outcomes of a novel office-based opioid treatment program in an internal medicine resident continuity practice
inferred← citeshttps://doi.org/10.1186/s13722-020-0177-xopenalex-snapshot
Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach
inferred← citeshttps://doi.org/10.1186/s13722-021-00223-zopenalex-snapshot
Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 “optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)”
inferred← citeshttps://doi.org/10.1186/s13722-021-00234-wopenalex-snapshot
The relationship between opioid agonist therapy satisfaction and fentanyl exposure in a Canadian setting
inferred← citeshttps://doi.org/10.1186/s13722-021-00263-5openalex-snapshot
Clinical leaders and providers’ perspectives on delivering medications for the treatment of opioid use disorder in Veteran Affairs’ facilities
inferred← citeshttps://doi.org/10.1186/s13722-025-00568-9openalex-snapshot
Implementing buprenorphine for opioid use disorder in veterans health administration primary care: a qualitative analysis
inferred← citeshttps://doi.org/10.1186/s13722-026-00699-7openalex-snapshot
Trait impulsivity prospectively predicts lower methadone treatment retention: moderation by pain catastrophizing
inferred← citeshttps://doi.org/10.13023/etd.2018.457openalex-snapshot
Using Prescription Drug Monitoring Data to Inform Population Level Analysis of Opioid Analgesic Utilization
inferred← citeshttps://doi.org/10.1371/journal.pgph.0000469openalex-snapshot
Factors associated with quality of life (QOL) scores among methadone patients in Myanmar
inferred← citeshttps://doi.org/10.14740/jcgo919openalex-snapshot
What to Expect With Pregnant or Postpartum Prescribing of Extended-Release Buprenorphine (CAM2038)
inferred← citeshttps://doi.org/10.1515/jci-2022-0077openalex-snapshot
Efficient and flexible mediation analysis with time-varying mediators, treatments, and confounders
inferred← citeshttps://doi.org/10.18103/mra.v10i8.2955openalex-snapshot
Is the Neuroimmune System a Therapeutic Target for Opioid Use Disorder? A Systematic Review
inferred← citeshttps://doi.org/10.18553/jmcp.2021.27.4.528openalex-snapshot
The effectiveness and value of digital health technologies as an adjunct to medication-assisted therapy for opioid use disorder
inferred← citeshttps://doi.org/10.21203/rs.3.rs-742094/v1openalex-snapshot
Treatment Satisfaction Among Clients Enrolled in Methadone Maintenance Treatment (MMT) Program in Myanmar: A Cross-sectional Study
inferred← citeshttps://doi.org/10.2139/ssrn.4209109openalex-snapshot
Examination of Methadone Involved Overdoses During the COVID-19 Pandemic
inferred← citeshttps://doi.org/10.2147/dddt.s72543openalex-snapshot
Advances in the delivery of buprenorphine for opioid dependence
inferred← citeshttps://doi.org/10.2196/33073openalex-snapshot
Patient- and Provider-Reported Experiences of a Mobile Novel Digital Therapeutic in People With Opioid Use Disorder (reSET-O): Feasibility and Acceptability Study
inferred← citeshttps://doi.org/10.2196/preprints.19700openalex-snapshot
Methadone and Suboxone® mentions on Twitter: Thematic and Sentiment Analysis (Preprint)
inferred← citeshttps://doi.org/10.22237/crp/1593562740openalex-snapshot
Medication assisted treatment with buprenorphine/naloxone or methadone: Comparitive outcomes in patients with an opioid addiction
inferred← citeshttps://doi.org/10.22237/crp/1698019260openalex-snapshot
Buprenorphine/suboxone is safe in pregnancy: substance use and stigma in the healthcare professions
inferred← citeshttps://doi.org/10.31031/tnn.2020.03.000572openalex-snapshot
Recent Advances in the Treatment of Opioid Use Disorders
inferred← citeshttps://doi.org/10.31219/osf.io/srxd3openalex-snapshot
Outcomes of State Targeted/Opioid Response grants and the Medication First approach: evidence of racial inequities in improved treatment access and retention
inferred← citeshttps://doi.org/10.31887/dcns.2017.19.3/msoykaopenalex-snapshot
Treatment of opioid dependence with buprenorphine: current update
showing the first 200 of 216 · page through all 216
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.